Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-01-30 · accession 0001628280-26-005157 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-01-30 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | F - Tax | $20.54 | -17.1K | 144.4K | -11% | -$351.9K | |
| 2026-02-03 | 2026-02-02 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | S - Sale | $20.53 | -13.1K | 131.3K | -9% | -$269.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-30 | F | D | 17,134 | $20.54 | 144,440 | D | — | — | (F1) Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. |
| 2 | Common | Common Stock | 2026-02-02 | S | D | 13,137 | $20.53 | 131,303 | D | — | — | (F2) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |